Error! You must javascript enabled to use this form. Please enable Javascript in your browser. With a CAGR of 30.4%, Short Bowel Syndrome Market to Rise a Valuation of US$2.6 Bn by 2024 GLP-2 Drug Shows Steady Growth during Forecast Period due to Popularity View full press release Your Name: Your Email: Subject: Question: We respects your privacy, the information you entered above will not be used to send unsolicited email, and will not be rented or sold to a 3rd party. Your contact information will be shared with the recipient of this message - Privacy Policy Send